GR73839B - - Google Patents

Info

Publication number
GR73839B
GR73839B GR59809A GR790159809A GR73839B GR 73839 B GR73839 B GR 73839B GR 59809 A GR59809 A GR 59809A GR 790159809 A GR790159809 A GR 790159809A GR 73839 B GR73839 B GR 73839B
Authority
GR
Greece
Application number
GR59809A
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of GR73839B publication Critical patent/GR73839B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR59809A 1978-08-11 1979-08-09 GR73839B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9783278A JPS5527105A (en) 1978-08-11 1978-08-11 Imidazothienopyrimidinones compound

Publications (1)

Publication Number Publication Date
GR73839B true GR73839B (el) 1984-05-04

Family

ID=14202683

Family Applications (1)

Application Number Title Priority Date Filing Date
GR59809A GR73839B (el) 1978-08-11 1979-08-09

Country Status (16)

Country Link
US (1) US4284773A (el)
EP (1) EP0008408B1 (el)
JP (1) JPS5527105A (el)
AU (1) AU529068B2 (el)
CA (1) CA1116597A (el)
CS (1) CS219256B2 (el)
DE (1) DE2961552D1 (el)
DK (1) DK153844C (el)
ES (1) ES483289A1 (el)
GR (1) GR73839B (el)
IL (1) IL57923A (el)
MX (1) MX6242E (el)
PH (1) PH15530A (el)
SU (1) SU880252A3 (el)
YU (1) YU41170B (el)
ZA (1) ZA793909B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287340A (en) * 1979-08-27 1981-09-01 Warner-Lambert Company Dihydro-oxo-pyrido[1,2-a]thienopyrimidine compounds
ZW11781A1 (en) * 1980-06-27 1982-01-20 Hoffmann La Roche Pyrimidine derivatives
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
GB0808950D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
KR102034748B1 (ko) 2011-03-01 2019-10-21 시너지 파마슈티컬즈 인코포레이티드 구아닐레이트 사이클라제 c 작용제의 제조 방법
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same
WO2015021358A2 (en) 2013-08-09 2015-02-12 Dominique Charmot Compounds and methods for inhibiting phosphate transport
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890321A (en) * 1971-09-20 1975-06-17 Pfizer 6-aryl-5-ethyl-pyrimidin-4-ol compounds useful as intermediates and bronchodilators
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
DE2411273A1 (de) * 1974-03-06 1975-09-18 Schering Ag Neue thieno eckige klammer auf 2,3-d eckige klammer zu pyrimidinone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IL57923A0 (en) 1979-11-30
CS219256B2 (en) 1983-03-25
SU880252A3 (ru) 1981-11-07
PH15530A (en) 1983-02-09
MX6242E (es) 1985-01-28
US4284773A (en) 1981-08-18
AU4973579A (en) 1980-02-14
YU194779A (en) 1983-10-31
CA1116597A (en) 1982-01-19
EP0008408A1 (en) 1980-03-05
YU41170B (en) 1986-12-31
ES483289A1 (es) 1980-09-01
DK153844B (da) 1988-09-12
EP0008408B1 (en) 1981-12-09
ZA793909B (en) 1980-10-29
IL57923A (en) 1982-09-30
AU529068B2 (en) 1983-05-26
JPS5527105A (en) 1980-02-27
DK153844C (da) 1989-01-30
DE2961552D1 (en) 1982-02-04
JPS627914B2 (el) 1987-02-19
DK336779A (da) 1980-02-12

Similar Documents

Publication Publication Date Title
CH628197GA3 (el)
DE2953954A1 (el)
GR73839B (el)
FR2416539B1 (el)
DE2954052A1 (el)
FR2416187B3 (el)
FR2414166B3 (el)
FR2414297B1 (el)
FR2416190B1 (el)
FR2416142B1 (el)
FR2415003B2 (el)
FR2415498B1 (el)
BG25957A1 (el)
BG25952A1 (el)
BG25879A1 (el)
BG26007A1 (el)
BG25858A1 (el)
BG25857A1 (el)
BG26006A1 (el)
BG25974A1 (el)
BG25973A1 (el)
BG25854A1 (el)
BG25972A1 (el)
BG25971A1 (el)
BG26009A1 (el)